MA
43
-3
URBN
70
-4
FLS
65
2
INTU
60
8
UPS
32
-6
WMB
55
4
HRL
39
3
KMI
63
6
OI
47
-2
ABBV
57
-2
EXR
22
-17
CF
48
3
FITB
75
3
ETN
67
4
ALLE
39
-5
RL
76
-2
SNA
53
3
SIG
41
-3
GLW
65
4
MNST
56
-3
MA
43
-3
URBN
70
-4
FLS
65
2
INTU
60
8
UPS
32
-6
WMB
55
4
HRL
39
3
KMI
63
6
OI
47
-2
ABBV
57
-2
EXR
22
-17
CF
48
3
FITB
75
3
ETN
67
4
ALLE
39
-5
RL
76
-2
SNA
53
3
SIG
41
-3
GLW
65
4
MNST
56
-3
Financhill
Back

Aclaris Therapeutics, Inc. Stock Predictions

Still Time to Get In: RAD Intel at $0.85/Share

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
81

ACRS
Aclaris Therapeutics, Inc.

Last Price:
$2.96
Seasonality Move:
43.1%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Powerhouse Raises Price - But Room Remains

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Aclaris Therapeutics, Inc. Stock Forecast

  • Is Aclaris Therapeutics, Inc. Stock Undervalued?
    The current Aclaris Therapeutics, Inc. [ACRS] share price is $3.01. The Score for ACRS is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
  • ACRS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.

Will Aclaris Therapeutics, Inc. Stock Go Up Next Year?

Data Unavailable

Aclaris Therapeutics, Inc. Stock Rating

Data Unavailable

Aclaris Therapeutics, Inc. Stock Price History

Is ACRS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
aclaristx.com

52-Week Data

52-Week High:
4.03
52-Week Low:
1.05

Prediction Charts

Market Cap:
326.1M
Price in USD:
3.01
Volume:
1.6M
Beta:
0.76

Technical Analysis

SMA50:
2.27
SMA100:
2.02
SMA200:
1.76
52-Wk Change:
-19.95%

Stock Predictions

  • Is Aclaris Therapeutics, Inc. stock public?
    Yes, Aclaris Therapeutics, Inc. is a publicly traded company.
  • What is the Aclaris Therapeutics, Inc. stock quote today?
    The Aclaris Therapeutics, Inc. stock price is 3.01 USD today.
  • How to buy Aclaris Therapeutics, Inc. stock online?
    You can buy Aclaris Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-14 2.28 2.52 2.61 2.25
Nov-17 2.51 2.45 2.60 2.43
Nov-18 2.45 2.49 2.55 2.38
Nov-19 2.50 2.46 2.55 2.41
Nov-20 2.47 2.41 2.57 2.39
Nov-21 2.34 2.51 2.56 2.34
Nov-24 2.53 2.75 2.78 2.46
Nov-25 2.76 2.73 2.77 2.65
Nov-26 2.73 2.88 2.90 2.70
Nov-28 2.90 2.83 2.92 2.76
Dec-1 2.79 2.61 2.82 2.61
Dec-2 2.64 2.70 2.74 2.59
Dec-3 2.71 2.78 2.90 2.66
Dec-4 2.75 3.01 3.08 2.72

Aclaris Therapeutics, Inc. Earnings

Data Unavailable

Aclaris Therapeutics, Inc. Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.07 per share.

* Aclaris Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.